Engineering the perfect (bacterial) cancer therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20944664.
- Also identified by DOI 10.1038/nrc2934 and PMC identifier 3756932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Medical subject headings
- Clostridium
- Genetic Engineering
- Neoplasms
- Salmonella